Global Epigenetics Market – Top Trends, Drivers, and Forecasts by Technavio – Business Wire (press release)

LONDON--(BUSINESS WIRE)--Technavios latest market research report on the global epigenetics market provides an analysis of the most important trends expected to impact the market outlook from 2017-2021. Technavio defines an emerging trend as a factor that has the potential to significantly impact the market and contribute to its growth or decline.

According to Amber Chourasia, a lead analyst at Technavio for lab equipment research, The global epigenetics market is expected to grow at a CAGR of over 13% through 2021, owing to factors such as the increasing importance of life science. It has claimed a prominent position in the research of developmental and disease processes. There has been a surge in the use of epigenetic changes in cancer research to study tumor biology and to produce therapeutic drugs.

This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

The top three emerging market trends driving the global epigenetics market according to Technavio research analysts are:

Looking for more information on this market? Request a free sample report

Technavios sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.

Increasing use of epigenetics as a tool to understand development and disease

Novel epigenetic techniques allow researchers to directly analyze the patterns of epigenetic modifications and relate them with the occurrence of phenotype. It allows comparison of epigenetic changes between normal and diseased samples. This can aid in the evaluation of public health as epigenetic changes are directly influenced by environment and internal biological system.

Many new methods are being employed in the field of epigenetics such as ChIP and next-generation sequencing (NGS). ChIP allows the interaction of DNA and protein, and NGS allows to understand the gene sequence, which is altered due to epigenetic changes. Hence, increasing application of epigenetics for diagnosis and cancer prevention with the help of technologies such as DNA methylation and epigenetics therapy respectively will contribute to cancer control.

Increasing demand for personalized medicine

The demand for personalized medicine is increasing and is expected to grow in future with a CAGR of more than 10%. The development of whole genome technology, companion diagnostics, and the growing number of retail clinics are some reasons for its growth. This will, in turn, increase the demand for diagnostics such as epigenetic analysis to diagnose diseases of individuals and chart out customized treatment plans according to an individual's diagnostic response. Personalized medicine results in the better treatment of patients as epigenetic analysis allow understanding which medicine will have better effects and which will not because every biological system has different genomes, which react differently to a particular medicine.

The epigenetics market is contingent on the demand for personalized medicine, which is increasing with the growing healthcare expenditure, the increasing need for effective diagnostic procedures for cancer, and the increasing use of biomarkers for diagnostics, says Amber.

Rise in investment in R&D

The global expenditure on R&D has shown consistent growth in the last 10 years. It rose from USD 522 billion in 1996 to approximately USD 1.3 trillion in 2009. With the economies of developing countries growing faster than that of developed countries, several institutes and research facilities are being set up in the developing countries. The rise in the number of testing and research facilities, particularly in the field of biotechnology and pharmaceuticals, will lead to a rise in demand for epigenetic analysis for diagnosis of diseases and development of therapeutic drugs.

The increase in R&D translates to an expansion of facilities in fields like clinical research and pharmaceutical research, which are all primary users of epigenetics as they require epigenetic equipment for diagnosing epigenetic alterations and providing drugs against it. Thus, the growth in these areas will lead to a rise in demand for epigenetic equipment during the forecast period.

Browse Related Reports:

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavios report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at media@technavio.com.

Excerpt from:
Global Epigenetics Market - Top Trends, Drivers, and Forecasts by Technavio - Business Wire (press release)